Global surgical implant company, RTI Surgical Inc. has announced tissue matrix line extensions in international markets.
RTI Surgical is a leading global surgical implant company providing surgeons with safe biologic, metal and synthetic implants. The company’s implants are used in sports medicine, general surgery, spine, orthopedic, trauma and cardiothoracic procedures and are distributed in nearly 50 countries.
RTI’s latest addition to the Fortiva® Tissue Matrix line is its 1mm configuration which it describes as a “next generation tissue matrix derived from porcine dermis.”
Fortiva Tissue Matrix 1mm is thinner and more pliable than Fortiva Tissue Matrix 1.5mm products, which are used for complex abdominal wall reconstruction. Fortiva Tissue Matrix 1mm was specifically designed for breast reconstruction that requires a thicker barrier than the Tutomesh 0.5mm Perforated between the implant and the surrounding tissues.
RTI Surgical also offers the Tutomesh 0.5mm Perforated, a thin yet strong bovine pericardium with an average thickness of just 0.5mm. This complements the Cortiva™ 1mm Allograft Dermis, an option for patients that require an allograft alternative. With the addition of Fortiva Tissue Matrix 1mm, RTI is unique in offering this full range of tissue matrix options with different thicknesses, perforated and non-perforated variants, and three different source materials.
Recently, the first implantation of the Fortiva Tissue Matrix 1mm was performed by Dr. med. Tanja Mitschele, a Oberärztin Fachärztin für Plastische und Ästhetische Chirurgie (specialist in plastic and aesthetic surgery) at the Klinikum Ingolstadt GmbH in Germany. Dr. med. Mitschele has prior experience with the thicker Fortiva 1.5mm. “Fortiva 1mm is more pliable and gentle than the Fortiva Tissue Matrix 1.5mm,” said Dr. med. Mitschele. “The 1mm option allows you to model it better to the breast compared to the previous thicker version, and the needle tip of the suture does not blunt as quickly as with the Fortiva 1.5mm.”
Keith Pelatowski, Vice President and General Manager, International, stated; “For our international markets, we now provide an option for patients who require maximum implant strength that is long lasting and with more consistent thickness – more consistent thickness means less graft to graft variance and is essential for bilateral procedures.”
He added “This offers an unrivalled range to surgeons, hospitals and their patients, allowing a multitude of options for breast reconstruction surgery. RTI is dedicated to becoming a leader in the field of breast reconstruction and complex abdominal wall surgery through the continual expansion of its high quality line of tissue matrices.”
Source: Business Wire